Pfizer First to Seek Full FDA Approval

Pfizer and its partner BioNTech have asked the Food and Drug Administration for full approval of their coronavirus vaccine for people ages 16 and older. The vaccine and two others are currently available in the United States under an emergency authorization from FDA. Pfizer and BioNTech are the first Covid-19 vaccine makers to seek full approval from U.S. regulators, which would allow the companies to market the shot directly to consumers. It could also make it easier for schools, employers and the military to require vaccination against Covid-19.

Pfizer and BioNTech also asked the regulatory agency to allow an expansion of emergency use of the vaccine to people ages 12 to 15.

Click here for more info.